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Abstract
Background: Trypanosoma cruzi, the agent of Chagas disease in humans, has a vast reservoir of mammalian hosts
in the Americas, and is classified into six genetic lineages, TcI-TcVI, with a possible seventh, TcBat. Elucidating
enzootic cycles of the different lineages is important for understanding the ecology of this parasite, the emergence
of new outbreaks of Chagas disease and for guiding control strategies. Direct lineage identification by genotyping
is hampered by limitations of parasite isolation and culture. An indirect method is to identify lineage-specific
serological reactions in infected individuals; here we describe its application with sylvatic Brazilian primates.
Methods: Synthetic peptides representing lineage-specific epitopes of the T. cruzi surface protein TSSA were used in
ELISA with sera from Atlantic Forest Leontopithecus chrysomelas (golden-headed lion tamarin), L. rosalia (golden lion
tamarin), Amazonian Sapajus libidinosus (black-striped capuchin) and Alouatta belzebul (red-handed howler monkey).
Results: The epitope common to lineages TcII, TcV and TcVI was recognised by sera from 15 of 26 L. chrysomelas and 8
of 13 L. rosalia. For 12 of these serologically identified TcII infections, the identity of the lineage infection was confirmed
by genotyping T. cruzi isolates. Of the TcII/TcV/TcVI positive sera 12 of the 15 L. chrysomelas and 2 of the 8 L. rosalia also
reacted with the specific epitope restricted to TcV and TcVI. Sera from one of six S. libidinous recognised the TcIV/TcIII
epitopes.
Conclusions: This lineage-specific serological surveillance has verified that Atlantic Forest primates are reservoir hosts
of at least TcII, and probably TcV and TcVI, commonly associated with severe Chagas disease in the southern cone
region of South America. With appropriate reagents, this novel methodology is readily applicable to a wide range of
mammal species and reservoir host discovery.
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Background
Trypanosoma cruzi is the causative agent of Chagas dis-
ease, regarded as the most important parasitic disease in
Latin America with a burden of 0.67 million disability-
adjusted life years (DALY) [1, 2]. Trypanosoma cruzi has
a complex system of domestic, peridomestic and sylvatic
transmission cycles involving mammals, triatomines and
humans, some of which overlap and may interact, some
of which may be entirely disparate. Enzootic in sylvatic
mammalian species from southern states of the USA to
Southern Argentina, T. cruzi is found in seven orders
and a huge range of species representing a vast reservoir
for the parasite [3, 4].
Trypanosoma cruzi exhibits great genetic diversity and
is currently classified into six distinct genetic lineages,
TcI-VI, with a possible seventh, TcBat [5–7]. It has been
suggested that the distribution of the distinct lineages is
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associated with different geographies, ecosystems,
mammalian hosts and even clinical presentation of the
human disease. However current associations are
restricted and fragmentary due to both the scarce sam-
pling in some settings and the difficulty in isolating and
genotyping T. cruzi from sylvatic mammals, potentially
resulting in an oversimplification or misinterpretation of
these lineage-specific findings [7–10]. The parasite may
be identified in blood films in the acute phase but is very
rarely found in peripheral blood in the chronic phase
and so haemocultures, xenodiagnoses or amplification of
DNA by PCR from blood may be applied, with low
sensitivity.
TcI is the most widespread recorded lineage, both
geographically and in sylvatic mammalian species, while
TcII is common in the domestic cycle [7, 9]. Neverthe-
less, TcII is increasingly reported in sylvatic mammals in
Southern American biomes, particularly in the Brazilian
Atlantic Forest [4, 7]. Jansen et al. [5] found 58% of T.
cruzi isolates from Brazilian sylvatic mammals to be TcI
while 17% were TcII. TcIII is seldom isolated from
humans, whereas TcIV is a secondary cause of Chagas
disease in Venezuela and in the Brazilian Amazon region
[7, 11, 12]. TcV and TcVI are relatively recent hybrids of
TcII and TcIII and along with TcII have largely been
associated with the domestic cycle, while sylvatic hosts
are presently not clearly defined [7, 11, 13, 14]. It is par-
ticularly desirable to identify the mammalian reservoir of
these lineages in the Southern Cone region due to their
implication in severe human disease in the form of
megacolon, megaoesophagus and chagasic cardiomyop-
athy [7, 13].
As the epidemiological picture of Chagas disease in
Latin America shifts, the sylvatic reservoir becomes
increasingly important. Currently an estimated 8 million
people are affected in 21 countries [1, 15]. However, the
distribution is changing with migration both from rural
to urban areas and from endemic to non-endemic
countries [15, 16]. Domestic transmission by Tria-
toma infestans was officially eliminated in Brazil in
2006 [16–18]. Cases of oral transmission are now
more frequently observed, and sporadic cases arising
from sylvatic adult triatomines entering dwellings [16,
19–22]. Of more than 1,000 acute infections of Cha-
gas disease reported in Brazil during 2000–2010, 776
(71%) were considered to have been acquired by the
oral route from contaminated juices or foods, the ma-
jority in the Amazon region of Brazil [21, 23–25].
Knowledge of the vector, host and geography of indi-
vidual lineages is limited by the difficulty in isolating the
parasite, which sequesters in host tissue. Currently
several serological assays are in use, however these do
not give any insight into the specific infecting lineages
and as such an indirect method that can identify
lineage-specific infection history is desirable in order to
elucidate the ecological cycles of the lineages and aid
discovery of novel mammalian reservoirs. [20]. Lineage-
specific serology requires an antigen sufficiently poly-
morphic both at the genetic locus and in the amino acid
sequence produced. The Trypomastigote Small Surface
Antigen (TSSA), a surface protein of the bloodstream
trypomastigote, was originally identified as having two
alleles corresponding to the lineages TcI and TcII (which
at that time encompassed TcII-VI) and was the first
serological marker to identify the lineage of human
infection [26]. Chagasic patients were only TSSA-II sero-
positive, which led to the suggestion that TcI could be
benign. However, this suggestion was in conflict with the
geographical predominance of TcI and occurrence of
chagasic cardiomyopathy north of the Amazon [10, 27].
Further molecular analysis of TSSA by Bhattacharyya et
al. [28] demonstrated much greater diversity at this
locus, with an increased number of lineage-specific epi-
topes, implying potential for serology that can differenti-
ate between lineages. The sequence previously described
as being shared by TcII-VI was shown to be restricted in
distribution to TcII, TcV and TcVI, whilst TcIII and TcIV
each have their own distinct lineage-specific epitope,
although only differing from each other by two amino
acids. The TSSA locus is heterozygous in the hybrid lin-
eages TcV and TcVI and encodes for a further TSSA
peptide that they share, differing from the TcII epitope
by a single amino acid substitution [11, 28]. BLAST
searches against available T. cruzi sequences have con-
firmed that these epitopes are conserved within their
lineages, and furthermore, comprehensive searches have
not detected the epitopes in any other organisms. Syn-
thetic peptides representing lineage-specific epitopes
have been used in an ELISA to identify infecting line-
ages in human chagasic sera from a range of endemic
countries, demonstrating a geographical and clinical vari-
ation in epitope recognition [11]. However, the TSSApep-I
gave no clear specific reaction with human chagasic sera
from TcI endemic regions, potentially due to low
immunogenicity or a conformation of the peptide differing
from that of the native antigen. Cimino et al. [29] have
published the only study on lineage-specific serology in
naturally infected mammals, demonstrating positive re-
sults with an ELISA using E. coli produced recombinant
TSSA-II antigen (the epitope shared by TcII, TcV and
TcVI) when applied to Argentinian canine sera. Bhatta-
charyya et al. [13] have also applied an expanded range of
TSSA epitopes in an ELISA with synthetic lineage-specific
peptides and experimentally infected mouse sera, with a
pilot study of a small range of sylvatic Brazilian primates.
Here we have applied a serological test using lineage
specific TSSA epitopes to the sera of Brazilian primates
from the Atlantic Forest and Amazon regions, in order
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to identify the historic infecting lineage(s) and further
expand knowledge of transmission cycles in these
biomes.
Methods
Primate sera
Archived sera were used from the cryobanks of Fiocruz,
Rio de Janeiro, which had been obtained from ongoing
field research. The following species were tested: Leonto-
pithecus rosalia (golden lion tamarin) (n = 16) of Silva
Jardim municipality, Rio de Janeiro State, Leontopithecus
chrysopygus (black lion tamarin) (n = 1) of Guapimirim
in Rio de Janeiro State, Leontopithecus chrysomelas
(golden-headed lion tamarin) (n = 33) of Una municipal-
ity in Bahia, Alouatta belzebul (red-handed howler mon-
key) (n = 8) of Estreito, Maranhão State and Sapajus
libidinosus (black-striped capuchin) (n = 12) of Estreito,
Maranhão State. The geographical origins of these
animals are shown in Fig. 1. Haemoculture had been
performed on all samples and as far as possible lineage
of isolates obtained had been characterised by multiplex
polymerase chain reaction (PCR) of the mini-exon
region. This differentiates between TcI, TcII (TcII/V/VI),
TcIII/IV and Trypanosoma rangeli [8]. The indirect
fluorescent antibody test (IFAT) was performed on all
samples. Nine of the L. rosalia samples have been fur-
ther characterised using polymerase chain reaction:
restriction fragment length polymorphisms (PCR: RFLP),
by single nucleotide polymorphisms (SNPs) in the
HSP60 and GPI loci and by PCR amplification of the D7
divergent domain of the 24Sα rRNA gene (LSU rDNA),
as described by Lewis et al. [30].
TSSA lineage-specific peptides
Peptides TSSApep-II/V/VI, TSSApep-III, TSSApep-IV,
and TSSApep-V/VI, representing epitopes found in
those T. cruzi lineages, were synthesised with N-terminal
biotinylation. As shown in Fig. 2, these peptides differ by
crucial lineage-specific amino acids. As described above,
despite extensive application, TSSApep-I, representing
the TcI TSSA epitope, has rarely been recognised in
ELISA and thus was not used here. Details of the
peptide synthesis and bioinformatic analysis of their
antigenicity have been described previously [11].
Lineage-specific ELISA
Flat bottomed ELISA strip plates (767071: Greiner Bio-
one) were coated with 1 μg /100 μl/well of avidin
(A9275: Sigma-Aldrich, Gillingham, UK) diluted in 1×
carbonate-bicarbonate coating buffer (15 mM Na2CO3,
34 mM NaHCO3, pH 9.6) for binding to biotinylated
lineage-specific TSSApep, and separate wells were coated
directly with Y strain T. cruzi lysate (Biomanghuinos,
Fiocruz, RJ) at 0.2 μg /100 μl/well as a serological control.
Fig. 1 Map of Brazil showing the origins of primate samples tested using the lineage-specific
ELISA (http://d-maps.com/carte.php?num_car=24873&lang=en)
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Plates were covered with an adhesive sheet and incubated
overnight at 4 °C. The following day, unbound avidin and
lysate were removed, the wells washed three times with
PBS containing 0.05% (vol/vol) Tween 20 (P7949: Sigma-
Aldrich) (PBS/T), then wells were blocked with 200 μl
blocking buffer [PBS/2% skimmed milk powder (Premier
International Foods, Spalding, UK)] at 37 °C for 2 h. Fol-
lowing three washes, 1 μg/100 μl/well of lineage-specific
TSSApep in PBS/T containing 2% skimmed milk powder
(PBS/T/M) was incubated with the avidin-coated wells at
37 °C for 1 h. For each sample, one avidin-coated well
remained without peptide as a no-peptide control. Follow-
ing three washes, 100 μl/well of a 1:200 dilution of primate
serum in PBS/T/M was applied and incubated at 37 °C for
1 h. Following six washes, 100 μl/well of goat anti-human
IgG-HRP (A0170: Sigma-Aldrich) diluted 1:10,000 in PBS/
T/M was added, and incubated at 37 °C for 1 h. The wells
were then washed 6 times and developed by applying
100 μl/well of 3,3′,5,5′-Tetramethylbenzidine (Biomanguin-
hos Fiocruz, RJ), and incubated in the dark for 10–15 min
at room temperature. The reaction was stopped by
adding 50 μl/well of 2 M H2SO4 and the absorbance
values were then read at 450 nm. Replica plates were
run simultaneously.
Statistical analysis
Cut-off values for ELISAs were calculated from the
mean plus 3 standard deviations compared to negative
controls. The same negative sylvatic animal was used as
a control on every plate.
Results
TSSApep serology identifies hosts of specific T. cruzi
lineages
Figure 3 shows an example of T. cruzi lineage-specific
ELISA using primate sera, demonstrating the specific
nature of the TSSApep recognition. Table 1 and Fig. 4
summarise the ELISA results with the primate samples.
Table 1 gives the peptide results in seropositive primates
tested by species, including the previous haemoculture
test results, while Fig. 4 presents the mean absorbance
value for each lineage-specific peptide for every sero-
positive animal tested. As observed previously with
human samples, a small proportion of the primate samples,
across four different species reacted non-specifically with
avidin [11]. Such primate samples were excluded from the
analysis and were not included in Table 1 or Fig. 4.
Sera from primates from both the Amazonian region
and the Atlantic Forest recognised lineage-specific pep-
tides. The majority of peptide reactions were to
TSSApep-II/V/VI (23/53 animals, excluding non-specific
reaction), the epitope present in TcII, TcV and TcVI.
Figure 3 provides examples of this peptide recognition
by both L. rosalia and L. chrysomelas sera, indicative of
infection with TcII, TcV or TcVI. Of those animals that
had isolates genotyped as TcII by mini-exon typing (TcII,
TcV or TcVI) a high proportion reacted with the epitope
common to TcII, TcV and TcVI (11/20 excluding non-
specific reactors) while seven of these 11 also reacted
with TSSApep-V/VI, representing infection with a hybrid
lineage TcV or TcVI. Only one Amazonian primate
reacted with lineage-specific peptides, this being the S.
libidinosus sampled in the Estreito municipality, in the
Amazon region. This animal responded to both
TSSApep-III and TSSApep-IV, which differ by only 2 of
16 residues, which is likely due to cross-reaction
between these epitopes. The majority of Amazonian pri-
mates tested did not react with peptides or lysate and
any IFAT titres were low, ranging from 1/10 to 1/40,
whereas the sample that produced peptide reactions had
a titre of 1/320. However, in the other species tested, L.
rosalia and L. chrysomelas, titre value appeared to show
Fig. 2 Trypanosoma cruzi lineage-specific peptides (TSSApep) used in primate serology. a The components of the peptides synthesised:
N-terminal biotinylation; PEG spacer; Gly; the lineage-specific sequence; C-terminal Cys. b The amino acid sequences of the lineage-specific TSSA
epitopes in the synthetic peptides (TSSApep-). Polymorphic residues are underlined. Abbreviations: Cys, cysteine residue; Gly, glycine residue; PEG,
polyethylene glycol
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no correlation with the presence or absence of peptide
reactions, with reactions present in samples with IFAT
titres ranging from 1/20 to 1/320 in L. chrysomelas and
from 1/40 to 1/160 in L. rosalia. Peptide reactions were
produced regardless of a negative or positive haemocul-
ture result in these species. Samples from L. chrysomelas
from Una, Bahia State, which reacted with TSSApep-II/V/
VI were much more likely to also give a reaction to the TcV
and TcVI restricted epitope in comparison to those of L.
rosalia animals [80% (12/15) and 25% (2/8), respectively]
from Silva Jardim, Rio de Janeiro State (Fig. 4). This indi-
cates hybrid lineage infection in both species, potentially in
conjunction with TcII infection. However, reaction to solely
TSSApep-V/VI in the absence of recognition of TSSApep-
II/V/VI was not seen, in accord with observation on human
sera [11]. The L. rosalia samples were obtained over the
period January 1996 to July 2005, while the L. chrysomelas
samples tested were obtained between January 2003 and
Fig. 3 TSSApep lineage-specific ELISA in primates. The plate shows both TSSApep-II/V/VI only and TSSApep-II/V/VI and TSSApep-V/VI reactions in L.
rosalia samples, TSSApep-II/V/VI and TSSApep-V/VI reactions in L. chrysomelas and a TSSApep-III and TSSApep-IV reaction in S. libidinosus samples
Table 1 Comparison of TSSApep ELISA reactions with haemoculture and genotyping data. All samples had tested positive for T.
cruzi infection with IFAT. Seven samples reacted non-specifically and are excluded (see text)
Species Biome Region Haemoculture Genotypinga nb TSSA peptide reaction
II/V/VI III IV V/VI Lysatec
L. chrysomelas Atlantic
Rainforest
Una, Bahia Positive I 1 1 0 0 1/1 of TSSA II/V/VI 0
II 11 8 0 0 6/8 of TSSA II/V/VI 5 (1)
Uncharacterised 6 4 0 0 4/4 of TSSA II/V/VI 3 (1)
Negative 8 2 0 0 1/2 of TSSA II/V/VI 5 (4)
L. chrysopygus Atlantic
Rainforest
Guapimirim, RJ Positive II 1 0 0 0 0 0
L. rosalia Atlantic
Rainforest
Silva Jardim, RJ Positive II 8 (4) 3 0 0 1/3 of TSSA II/V/VI 2
Mixed I/II 1 (1) 1 0 0 1/1 of TSSA II/V/VI 1
Uncharacterised 1 1 0 0 0 1
Negative 3 3 0 0 0 3
S. libidinosus Amazon Estreito, Maranhão Positive Uncharacterised 2 0 1d 1d 0 1d
Negative 4 0 0 0 0 0
A. bezebul Amazon Estreito, Maranhão Positive Mixed I/IV 1 0 0 0 0 0
Uncharacterised 1 0 0 0 0 1 (1)
Negative 5 0 0 0 0 0
aAll samples genotyped by PCR of the mini-exon
bParentheses indicate TcII infections confirmed by PCR:RFLP based on SNPs in the HSP60 and GPI loci and by PCR of LSU rDNA
cParentheses indicate samples that reacted with lysate only
dSame sample reacting with TSSApep-III and TSSApep-IV and lysate
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July 2005, with no apparent temporal aggregation of re-
sponse to peptides.
Both the one sample that had been previously identi-
fied as TcI by mini-exon assay and that diagnosed as a
mixed infection of TcI/II gave a positive reaction with
TSSApep-II/V/VI and TSSApep-V/VI suggestive of
mixed infections not isolated in haemoculture. Five
samples that had negative haemoculture and IFAT
results previously were also tested and of these one L.
chrysomelas sample gave a positive reaction with
TSSApep-II/V/VI, TSSApep-V/VI and the lysate (these
results are not included in Table 1). This emphasises the
importance of the application of multiple tests in order
to ascertain as much information as possible from the
limited available samples.
Discussion
In Brazil Chagas disease has been largely attributed to
TcII in the southern regions, while in Amazonia it has a
unique epidemiology with sporadic disease largely attrib-
uted to TcI, and to a lesser extent TcIII and TcIV. TcII,
TcV and TcVI have rarely been isolated in Amazonia, in
contrast to endemic regions of Brazil where they
predominate [3, 8].
Previous studies of the tamarins of the Atlantic Forest
have shown a variable distribution of infection by the
different T. cruzi lineages, with TcI and TcII predominat-
ing in different studies [31–36]. In particular, Lisboa et
al. [36], in a study of the Atlantic rainforest mammals,
found TcII to be present only in tamarins while TcI was
found in both Didelphis aurita (big-eared opossum) and
lion tamarins, with TcI predominating overall.
In the Amazon region, past research has largely
demonstrated TcI infection in primates, corresponding
with the principal agent of Chagas disease in humans in
this region [27, 31, 35]. More recently Marcili et al. [3]
isolated both TcI and TcIV (then known as TcIIa) from
Amazonian primates. In that study there was a higher
prevalence of TcI than TcIV corresponding to the preva-
lence seen in local Rhodnius species of triatomines and
humans with orally acquired T. cruzi infection [3].
This study showed lineage-specific reactions in pri-
mates both from the Atlantic Forest and the Amazon re-
gion. Both peptides TSSApep-II/V/VI and TSSApep-V/
Fig. 4 Distribution of lineage-specific TSSApep recognition. Individual lineage-specific ELISA results plotted as single data points (mean of duplicate
absorbance values read at 450 nm) for: a Amazonian primates, b L. chrysomelas, and c L. rosalia. The dotted line represents the negative cut-off point
for each peptide
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VI gave lineage-specific reactions with samples from the
Atlantic Forest. Sera of L. rosalia animals from Silva
Jardim in Rio de Janeiro State much more likely to react
solely with TSSApep-II/V/VI (75% of reactions, 6/8)
whilst L. chrysomelas from Una in Bahia State were
more likely to recognise both peptides (80%, 12/15). This
confirms circulation of TcII in lion tamarin populations
in both regions of Atlantic Forest sampled, while hybrid
lineages are also circulating in both species but to a
greater extent in golden-headed lion tamarins of Bahia
State. The Atlantic Forest is increasingly fragmented,
with the majority of fragments less than 50 hectares in
area and less than 12% of the original forest remaining,
with a consequent fragmentation of the wild population
of these species, potentially favouring the establishment
and maintenance of such distinct transmission cycles
[37]. The behavioural patterns of lion tamarins are also
likely to contribute to distinct transmission cycles in
small populations, including their tendency to live in
small family groups, occupy stable territories and sleep
in tree holes [34]. As such each piece of this fragmented
population must be considered as a separate unit in a
much larger, complex web of transmission cycles [34].
Triatomines have been found to infest the nests of co-
atis, using multiple feeding sources including the coatis
themselves; this may also occur in the tree holes of pri-
mates, with the primates also feeding on the bugs [38].
To the authors’ knowledge, the only isolates of these
hybrid lineages in Brazil have been from a dog in the
Amazon region as well as a sylvatic rodent, Trichomys
laurentius, and two opossums in the Caatinga [5, 8, 31].
Infectivity competence, which requires a sufficient para-
sitaemia, varies spatially and temporally, and in light of
previous findings our results, which come from samples
collected over a long period of time, must be viewed as
results at a point in time and space [5]. Various factors
impact upon the infectivity of a host mammal including
health, associated parasitic infections, behaviour and
contact with vector species, many of which are subject
to change as ecosystems suffer anthropogenic damage.
More extensive studies of these primates, although chal-
lenging for such sylvatic animals that must be protected,
would greatly enhance our understanding of transmis-
sion cycle dynamics.
Conversely only one Amazonian primate, a member of
the S. libidinosus species from Estreito municipality in
Maranhão State, produced peptide reactions. This was
to the TSSApep-III and TSSApep-IV. As cross-reaction
between these peptides, which vary by only two amino-
acids, has been reported previously it is not possible to
say definitively which lineage the animal is infected with,
TcIII, TcIV or both [11, 13]. Previous findings strongly
suggest TcIV infection in S. libidinosus; as far as we are
aware it has not previously been isolated from this
primate species [3]. This finding of a TcIII/TcIV reacting
primate may be supportive of an emerging human
disease threat in the Amazon, which could increase with
migration into the Amazon, deforestation, land use
change and encroachment on primate habitats by
human settlement. The lack of further peptide results in
the Amazonian primates tested, all of which were either
S. libidinosus or A. belzebul, may be related to lower
titre samples, but may also be related to the high level of
TcI infection amongst primates in this region. More
attempts should be made to design an efficacious TcI
specific peptide, for example by comparative genomics,
epitope prediction and expression library screening, to
seek alternative antigens to TSSA that may be lineage-
specific. If necessary, this should be done in conjunction
with structural analysis and design of linear peptides that
represent conformational epitopes. Peptides should be
applicable without avidin-binding to plates to enable in-
clusion of the few animals that have avidin-binding anti-
bodies. The international surveillance and control
programme AMCHA was set up by PAHO in 2004 to
tackle the rise in Chagas disease in the Amazon region
through surveillance and prevention [9, 20]. It is impera-
tive that the animal reservoir is included in this surveil-
lance. The Amazon region, which was said to be free of
TcII, has recently had this lineage isolated from both
triatomines and mammals (Canis familiaris) in two
Amazonian localities, highlighting the need for monitor-
ing of this continually evolving epidemiology [8].
Leontopithecus rosalia and L. chrysomelas have been
shown to be able to maintain long-lasting parasitaemias
with TcII [5, 35, 36]. The findings of our study, indicate
that both L. rosalia and L. chrysomelas are viable reser-
voirs of TcII and TcV/TcVI. Previous studies have shown
a high T. cruzi seroprevalence in both Amazonian pri-
mates (45.5%) and those of the Atlantic Forest (46%)
and this implies strong potential for these primates to
maintain a variety of lineages within their ecosystems,
potentially propagating the parasite to human popula-
tions who live increasingly side by side with these pri-
mates, which are kept as pets in some regions [34, 35].
These results demonstrate the diversity of T. cruzi lin-
eages circulating amongst primates in Brazil in different
ecotopes. Trypanosoma cruzi has a long evolutionary
history with the mammalian wildlife of Latin America
leading to the current distribution [39]. However, human
actions impact upon the biodiversity of these reservoirs
and may have implications for the distribution of the
parasite, whether by diluting parasite burden as a result
of maintaining biodiversity and thus decreasing disease
prevalence, or by maintaining the reservoir and perpetu-
ating the ongoing transmission cycles [40–43].
Pathological changes caused by T. cruzi may affect pri-
mates, including endangered species such as L. rosalia,
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L. chrysomelas and L. chrysopygus [44, 45]. ECG abnor-
malities as well as elevated cardiac lesion marker serum
levels have been seen in free-ranging naturally-infected
tamarins [45]. The lack of more severe changes may be
due to a lesser pathology produced by the parasite as a
result of the longer evolutionary relationship between
parasite and primate host, but may also be related to a
fitness cost for the animals, causing them to die before
these changes are detected, either by predation or by an
inability to cope in nature [45]. In the course of conser-
vation programmes wild species are frequently translo-
cated and, in light of the findings here indicative of both
TcII and TcV/VI infection in lion tamarins, it is import-
ant to do this in a responsible manner to avoid introdu-
cing new parasite populations to non-endemic regions
[34, 46]. Infections have also been recorded in captive
populations, with an active transmission cycle involving
Panstrongylus megistus being identified in a Brazilian
Zoo, which is probably an extension of that of a neigh-
bouring intact forest fragment [46]. This not only high-
lights the potential for primates to act as sources of
infection for humans, but also the potential for sylvatic
triatomines to invade other settings where they are in
close contact, such as human settlements at forest edges.
The finding of positive reaction with TSSApep-V/VI in
both L. rosalia and L. chrysomelas strongly suggests that
the tamarins are a reservoir of hybrid lineages in the At-
lantic Forest. We have observed with human samples
that only a minor proportion of TSSApep-II/V/VI reac-
tors also react with TSSApep-V/VI, indicating that it is
unlikely to be due to a general artefactual cross-reaction
between these peptides; we believe this to be in contrast
to the situation between TSSApep-IV/TSSApep-III re-
activity described herein and elsewhere [11].
Early South American mammals included the Didel-
phimorphia (opossums) Cingulata (armadillos) and
Pilosa (anteaters, sloths); the primates and caviomorph
rodents arrived later from Africa between 35 and 55 mil-
lion years ago [5, 47–49]. A reliance on vicariance bio-
geography has estimated the time of divergence between
New World and Old World trypanosomes to agree with
that of the divergence of Gondwanan landmasses [50].
However new theories have arisen proposing that try-
panosomes in the New World may have reached South
America much later, based on the diversity of the T.
cruzi clade, and surmise that a viable route of dispersion
may have been via bats which are known to be hosts of
a wide range of trypanosomes and are able to cross large
bodies of water [50]. Hamilton et al. [50] suggest that
the ancestor of T. cruzi and T. rangeli originated in bats
and was then seeded to South America via bat disper-
sion. However, with growing evidence of dispersal of
other species across dispersion barriers such as the At-
lantic Ocean there is potential for other mammals, such
as primates and caviomorph rodents to have aided in
this seeding. Primates are thought to have made their
long-distance journey approximately 40 million years
ago making this a viable option [47].
Conclusions
We have shown this ELISA to successfully identify
lineage-specific reaction even when haemoculture has
been negative, and even in one instance when IFAT
serology was also negative. The assay can be applied to
sylvatic primates and is a useful tool for understanding
the eco-epidemiology of the various lineages of T. cruzi
where isolation and genotyping are severely limited. In
particular, it indicates that the test may identify as yet
undetected reservoirs of TcV and TcVI and further our
understanding of the sylvatic cycles of these lineages. As
all mammal species are considered to be susceptible to
T. cruzi infection there would be great value in expand-
ing the test to a wide range of species in order to eluci-
date novel hosts. Future research is required in order to
refine this test in other species, as well as identifying a
TcI specific epitope that could be applied as a lineage-
specific peptide. Commercially available secondary anti-
bodies allow the ELISA to be applied to a greater variety
of species, however often the phylogenetic relationship
of species available is not as close as is ideal. It may be
desirable to use a pan-generic conjugate such as Protein
G, and to adapt the assay to a rapid diagnostic test for
point-of-capture application to animals in the field (work
in progress). With greater knowledge of sylvatic trans-
mission cycles there may be increased potential for
predicting outbreaks, particularly at the interface
between human activity and sylvatic mammalian habitats
where new cases are frequently seen, and producing
sustainable targeted control measures. Collaboration by
all those involved in studying aspects of the parasite, its
ecology and the dynamic social context within which it
sits will enhance this work.
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